TIGIT and hepatocellular carcinoma: In this study, we investigated the number of GrB+ cells, Tregs, and the expression of six immune checkpoints (CTLA‐4, PD‐1, LAG3, TIGIT, TIM3, and VISTA) in tissue samples from HCC patients.